by Admin Neo Lumina | Dec 14, 2023 | News
How psychedelics could help those living with alcohol use disorders Alcohol use disorders (AUD) are estimated to affect around 237 million people across the globe, with 3 million deaths each year attributed to the harmful use of alcohol. Despite this prevalence, there...
by Admin Neo Lumina | Dec 14, 2023 | News
Meta-analysis highlights potential of psilocybin therapy for treatment-resistant depression A scientific review and meta-analysis published in Psychiatry Research concludes that “well-designed phase III trials are urgently needed” to further examine the promising...
by Admin Neo Lumina | Dec 6, 2023 | News
Psychedelic therapy programmes launch to address heartbreak, burnout and more Mindbloom has launched its new Mastermind Series of psychedelic programmes for overcoming heartbreak, burnout and other unique mental health challenges. Led by and developed with leading...
by Admin Neo Lumina | Dec 1, 2023 | News
Canada recommends launch of Veterans psychedelic research programme A new report has been released by Canada’s Senate Subcommittee on Veterans Affairs – ‘The Time Is Now: Granting Equitable Access to Psychedelic Assisted Therapies’ – which recommends the launch of a...
by Admin Neo Lumina | Dec 1, 2023 | News
Psilocybin analogue shows positive results in Phase 2 depression study Cybin has announced positive Phase 2 topline safety and efficacy data for its proprietary deuterated psilocybin analogue – CYB003 – for the treatment of major depressive disorder (MDD). Results...
